Industry News


Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



Messe Frankfurt India and Andhra Pradesh MedTech Zone (AMTZ) join hands to launch MedTech Innovation Forum in India

With an objective to draw attention to the growth opportunities and latest developments in the Indian Medical device industry, Messe Frankfurt Trade Fairs India has joined hands with India’s first integrated medical devices manufacturing ecosystem – AMTZ. The joint cooperation aims to provide further impetus to indigenous manufacturing of medical devices and bring forward innovations and specialised medical tools and technologies that can attract domestic and global investors.

As the nation takes steps to develop its healthcare infrastructure including an ecosystem for its medical device industry, the launch of MedTech Innovation Forum aims to create a collaborative platform for medical device manufacturers, innovators and technology experts to exchange advancements and innovations for the development of the Indian medical devices industry.

Slated from 7 – 8 October 2021 in Visakhapatnam, the first edition of this key business event is expected to bring industry leadership together with government and medical consultants to address integral challenges of import dependency, need for technology collaborations as well as medical technology advancements that can be introduced in the industry. The forum has received strong support from apex industry bodies – AIMED (Association of Indian Medical Device Industry) and ADMI (Association of Diagnostics Manufacturers of India) ADMI.

Commenting on the development, Mr Raj Manek, Managing Director, Messe Frankfurt Trade Fairs India Pvt Ltd said: “India’s response and agility in scaling up manufacturing of medical devices together with strong initiatives by the government on making the sector ‘Atmanirbhar’ makes it opportune time to introduce a forum that focuses on bringing medical technology innovations to the forefront. We are proud to combine strengths with AMTZ in this goal and are confident that the critical insights on MedTech advancements and challenges will enable the sector to create an environment for improved trade and investment opportunities.”

The Indian medical devices market, which accounts for more than 13% of the Asia-Pacific (APAC) medical devices market, is expected to grow at a compound annual growth rate of 7.5% through 2025. Dr Jitendra Sharma, MD & CEO, Andhra Pradesh MedTech Zone elaborated: “The industry is poised for significant growth in the next five years, however, it is still largely importdriven with 90% of sophisticated devices being imported from around the world. The dialogue with medical device manufacturers and innovators will open up opportunities to empower the country’s strong healthcare and medical devices industry in the post COVID-19 era.

Dr Sharma further added that AMTZ aims to put the Indian medical device industry on the global map by encouraging sector innovations and we are happy to join hands with Messe Frankfurt in this endeavour as their expertise and reach across sectors in India will help bring in key stakeholders together.”

Messe Frankfurt India has been actively involved in tracking industry growth and addressing rising concerns on counterfeit products in the pharmaceutical industry through its Pharmasafe India conference and webinar series. In August 2020, the Indian subsidiary held the first virtual edition of the Medical Device Innovation Summit to address growing demand for specialised medical equipment and is now closely working with industry leaders in the sector to launch Medtech Innovation Forum as a large-format Confex in October 2021.

Touted as India’s largest medical devices manufacturing park, the Andhra Pradesh Medtech Zone (AMTZ) has dynamically contributed to the fight against COVID-19 pandemic through large-scale manufacturing of domestic rapid testing kits, PPE and ventilators. As a scientific infrastructure supported by the government, the zone intends to reduce import dependence and lower cost of healthcare by an estimated 40 to 50 per cent and is taking active steps to develop R&D, testing labs and provision for acceleration for start-ups.

Intake Of Students In Medical Devices Courses At NIPERs Increased To Strengthen Manpower Resources

Intake of students in medical devices courses at National Institute of Pharmaceutical Education and Research (NIPER) Mohali, Guwahati and Hyderabad has been increased to strengthen manpower resources for medical devices sector in the country.

Admission of 34 students has been made for the new course of M Tech (Medical Devices) with 11 seats in NIPER Mohali, nine in NIPER Guwahati and twelve in NIPER Hyderabad.

The government is also planning to explore every prospect of revenue generation in the existing seven NIPERs in the country to help them evolve into self-sustaining premier institutions. At present, there are seven NIPERs across the country at Mohali, Ahmedabad, Hyderabad, Rae Bareli, Guwahati, Hajipur and Kolkata.

The Government of India has termed NIPERs as Institutes of National Importance.

The Centre also has plans to strengthen industry-academia linkages which can also be leveraged to commercialize patents which are held by NIPERs.

The Union minister for chemicals and fertilizers D V Sadananda Gowda and Minister of State (MoS) for chemicals and fertilizers Mansukh Mandaviya had held a review meeting last year in the month of September to monitor functioning of NIPER Mohali and Rae Bareli through video conferencing. The meeting was also attended by Department of Pharmaceuticals (DoP) secretary Dr P D Vaghela and other senior officers.

NIPERs across the country play an important role in the development of upcoming bulk drug and medical device parks and the Centre has renewed its focus on drug discovery for diseases like TB, malaria, kala azar, cancer, diabetes, obesity, drug repurposing and drug development.

NIPERs across the country are today being developed as centers of excellence as R&D is the thrust of the present government with priority to support the MSME sector through extension of services like testing, consultancy and incubation centers.

NIPER Mohali has been ranked 3rd and NIPER Raebareli at 18th by NIRF in the pharmacy sector.

NIPERs are national level institutes in pharmaceutical sciences with the objective of becoming centres of excellence for advanced studies and research in pharmaceutical sciences.


Other News

Goldstab Organics Expands Capacity with new state-ofthe-art Calcium/Zinc Based PVC Stabilizer Plant





Back | Back To Top | Previous